Cellectar Biosciences Stock Technical Analysis
| CLRB Stock | USD 3.29 0.15 4.78% |
As of the 14th of February 2026, Cellectar Biosciences shows the Mean Deviation of 4.61, downside deviation of 5.88, and Risk Adjusted Performance of 0.0202. Cellectar Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cellectar Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cellectar, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CellectarCellectar | Build AI portfolio with Cellectar Stock |
Cellectar Biosciences Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 47.0 | Buy | 4 | Odds |
Most Cellectar analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cellectar stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cellectar Biosciences, talking to its executives and customers, or listening to Cellectar conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectar Biosciences. Projected growth potential of Cellectar fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cellectar Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Cellectar Biosciences requires distinguishing between market price and book value, where the latter reflects Cellectar's accounting equity. The concept of intrinsic value - what Cellectar Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Cellectar Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Cellectar Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cellectar Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cellectar Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cellectar Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cellectar Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cellectar Biosciences.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Cellectar Biosciences on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Cellectar Biosciences or generate 0.0% return on investment in Cellectar Biosciences over 90 days. Cellectar Biosciences is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercial... More
Cellectar Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cellectar Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cellectar Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.88 | |||
| Information Ratio | 0.0033 | |||
| Maximum Drawdown | 30.55 | |||
| Value At Risk | (7.25) | |||
| Potential Upside | 7.8 |
Cellectar Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellectar Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cellectar Biosciences' standard deviation. In reality, there are many statistical measures that can use Cellectar Biosciences historical prices to predict the future Cellectar Biosciences' volatility.| Risk Adjusted Performance | 0.0202 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0037 | |||
| Treynor Ratio | 0.0466 |
Cellectar Biosciences February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0202 | |||
| Market Risk Adjusted Performance | 0.0566 | |||
| Mean Deviation | 4.61 | |||
| Semi Deviation | 5.62 | |||
| Downside Deviation | 5.88 | |||
| Coefficient Of Variation | 7056.98 | |||
| Standard Deviation | 6.46 | |||
| Variance | 41.7 | |||
| Information Ratio | 0.0033 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0037 | |||
| Treynor Ratio | 0.0466 | |||
| Maximum Drawdown | 30.55 | |||
| Value At Risk | (7.25) | |||
| Potential Upside | 7.8 | |||
| Downside Variance | 34.52 | |||
| Semi Variance | 31.63 | |||
| Expected Short fall | (5.53) | |||
| Skewness | 0.5529 | |||
| Kurtosis | 2.81 |
Cellectar Biosciences Backtested Returns
Cellectar Biosciences appears to be slightly risky, given 3 months investment horizon. Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of 0.0611, which signifies that the company had a 0.0611 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Cellectar Biosciences, which you can use to evaluate the volatility of the firm. Please makes use of Cellectar Biosciences' Risk Adjusted Performance of 0.0202, mean deviation of 4.61, and Downside Deviation of 5.88 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cellectar Biosciences holds a performance score of 4. The firm shows a Beta (market volatility) of 1.75, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cellectar Biosciences will likely underperform. Please check Cellectar Biosciences' jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Cellectar Biosciences' price patterns will revert.
Auto-correlation | 0.76 |
Good predictability
Cellectar Biosciences has good predictability. Overlapping area represents the amount of predictability between Cellectar Biosciences time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cellectar Biosciences price movement. The serial correlation of 0.76 indicates that around 76.0% of current Cellectar Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cellectar Biosciences Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Cellectar Biosciences across different markets.
About Cellectar Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cellectar Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cellectar Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cellectar Biosciences price pattern first instead of the macroeconomic environment surrounding Cellectar Biosciences. By analyzing Cellectar Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cellectar Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cellectar Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
Cellectar Biosciences February 14, 2026 Technical Indicators
Most technical analysis of Cellectar help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cellectar from various momentum indicators to cycle indicators. When you analyze Cellectar charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0202 | |||
| Market Risk Adjusted Performance | 0.0566 | |||
| Mean Deviation | 4.61 | |||
| Semi Deviation | 5.62 | |||
| Downside Deviation | 5.88 | |||
| Coefficient Of Variation | 7056.98 | |||
| Standard Deviation | 6.46 | |||
| Variance | 41.7 | |||
| Information Ratio | 0.0033 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0037 | |||
| Treynor Ratio | 0.0466 | |||
| Maximum Drawdown | 30.55 | |||
| Value At Risk | (7.25) | |||
| Potential Upside | 7.8 | |||
| Downside Variance | 34.52 | |||
| Semi Variance | 31.63 | |||
| Expected Short fall | (5.53) | |||
| Skewness | 0.5529 | |||
| Kurtosis | 2.81 |
Cellectar Biosciences February 14, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cellectar stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,357 | ||
| Daily Balance Of Power | 0.62 | ||
| Rate Of Daily Change | 1.05 | ||
| Day Median Price | 3.27 | ||
| Day Typical Price | 3.28 | ||
| Price Action Indicator | 0.09 |
Complementary Tools for Cellectar Stock analysis
When running Cellectar Biosciences' price analysis, check to measure Cellectar Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectar Biosciences is operating at the current time. Most of Cellectar Biosciences' value examination focuses on studying past and present price action to predict the probability of Cellectar Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectar Biosciences' price. Additionally, you may evaluate how the addition of Cellectar Biosciences to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |